Medindia
Medindia LOGIN REGISTER
Advertisement

Medco Delivers Second-Quarter 2010 GAAP Diluted EPS Growth of 20.3 Percent to a Record $0.77; Diluted EPS, Excluding Amortization of Intangible Assets, Increased 20.3 Percent to a Record $0.83

Thursday, July 22, 2010 Drug News
Advertisement
Narrows Guidance Range for 2010 GAAP Diluted EPS; Narrows and Raises Guidance Range for Diluted EPS Excluding Amortization of Intangible Assets

Medco Health Solutions, Inc.Guidance Information(Unaudited)

Table 10.

Full Year Ended

Estimated

December 26, 2009

Full Year Ended December 25, 2010

Actual

Low End

High End

Earnings Per Share Guidance Reconciliation:

GAAP diluted earnings per share

$                        2.61

$                3.10

$                3.15

Adjustment for the amortization of intangible assets (1)

0.22

0.24

0.24

Diluted earnings per share, excluding intangible amortization

$                        2.83

$                3.34

$                3.39

Diluted earnings per share growth over prior year

19%

21%

Diluted earnings per share growth over prior year, excluding intangible amortization

18%

20%

 (1) This adjustment represents the per share effect of the intangible amortization from the 2003 spin-off, when Medco became  

 a publicly traded company.  

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close